Indirect suppression of IL-1β signaling by a caspase 1 inhibitor belnacasan (also known as VX-765) has been shown to ameliorate kidney damage and fibrosis in experimental AKI and CKD models but these beneficial effects may be also related to inhibition of pyroptosis (111–113). Here, IL1B is linked to acute kidney injury.